• 30TH MAY 2025

    May 2025 Price Concessions Final Update

    The Department of Health and Social Care (DHSC) has today (30/05/2025) confirmed the following final list of price concessions for May 2025.  Drug Pack size Price concession Acetazolamide 250mg tablets 112 £47.22 Cefradine 500mg capsules 20 £13.44 Conjugated oestrogens 1.25mg tablets 84 £52.56 Conjugated oestrogens 300microgram tablets 84 £24.02 Conjugated oestrogens 625microgram tablets 84 £26.87 Duloxetine

    Read more
    • 29TH MAY 2025

    Reminder: Pharmacy First bundling requirement from 1st June

    There is now less than one week to go before the bundling requirements for Pharmacy First come into force, which will impact on whether pharmacy owners are entitled to a monthly fixed payment for the service. From 1st June 2025, pharmacy owners must be registered and able to deliver the Hypertension Case Finding Service*, the

    Read more
    • 28TH MAY 2025

    2025 Community Pharmacy England Workshops

    Ahead of negotiations on the Community Pharmacy Contractual Framework (CPCF) for 2026/27 any beyond, Community Pharmacy England is keen to discuss pressing issues and the future of the sector with pharmacy owners and LPCs. All pharmacy owners and their representatives are therefore invited to attend our regional ‘Future of Pharmacy’ workshops to discuss what next

    Read more
    • 28TH MAY 2025

    Reminder: Submit your FP34C declaration and prescription bundles on time

    Community Pharmacy England would like to remind pharmacy owners of the requirement to submit their FP34C declaration using the Manage Your Service (MYS) portal and to dispatch any prescription bundles to the relevant pricing division at the NHS Business Services Authority (NHSBSA) no later than the 5th day of the month following that in which

    Read more
    • 28TH MAY 2025

    4 products re-classified as special containers from June 2025

    Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 June 2025. Generic drug name (dm+d descriptor) Brand and/or Manufacturer Pack size Special container Carmellose 1% eye drops 0.4ml unit dose preservative free Celluvisc® 1% eye drops

    Read more